These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 8237996)
21. Reassessment of von Willebrand factor (VWF), VWF propeptide, factor VIII:C and plasminogen activator inhibitors 1 and 2 during normal pregnancy. Sié P; Caron C; Azam J; Goudemand J; Grandjean H; Boneu B; Fournié A Br J Haematol; 2003 Jun; 121(6):897-903. PubMed ID: 12786801 [TBL] [Abstract][Full Text] [Related]
22. Hemostasis in patients with severe von Willebrand disease improves after normal platelet transfusion and normalizes with further correction of the plasma defect. Castillo R; Escolar G; Monteagudo J; Aznar-Salatti J; Reverter JC; Ordinas A Transfusion; 1997 Aug; 37(8):785-90. PubMed ID: 9280321 [TBL] [Abstract][Full Text] [Related]
23. Hermansky-Pudlak syndrome and oculocutaneous albinism in Chinese children with pigmentation defects and easy bruising. Power B; Ferreira CR; Chen D; Zein WM; O'Brien KJ; Introne WJ; Stephen J; Gahl WA; Huizing M; Malicdan MCV; Adams DR; Gochuico BR Orphanet J Rare Dis; 2019 Feb; 14(1):52. PubMed ID: 30791930 [TBL] [Abstract][Full Text] [Related]
24. Hermansky-Pudlak syndrome subtype 5 (HPS-5) novel mutation in a 65 year-old with oculocutaneous hypopigmentation and mild bleeding diathesis: The importance of recognizing a subtle phenotype. Botero JP; Chen D; Majerus JA; Coon LM; He R; Warad DM; Pruthi RK; Nichols WL Platelets; 2018 Jan; 29(1):91-94. PubMed ID: 29090612 [TBL] [Abstract][Full Text] [Related]
25. Hermansky-Pudlak syndrome in a Swiss population. Schallreuter KU; Frenk E; Wolfe LS; Witkop CJ; Wood JM Dermatology; 1993; 187(4):248-56. PubMed ID: 8274781 [TBL] [Abstract][Full Text] [Related]
26. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease. Böhm M; Täschner S; Kretzschmar E; Gerlach R; Favaloro EJ; Scharrer I Blood Coagul Fibrinolysis; 2006 Jan; 17(1):39-45. PubMed ID: 16607078 [TBL] [Abstract][Full Text] [Related]
27. Evidence for locus heterogeneity in Puerto Ricans with Hermansky-Pudlak syndrome. Hazelwood S; Shotelersuk V; Wildenberg SC; Chen D; Iwata F; Kaiser-Kupfer MI; White JG; King RA; Gahl WA Am J Hum Genet; 1997 Nov; 61(5):1088-94. PubMed ID: 9345105 [TBL] [Abstract][Full Text] [Related]
28. Further evidence for recessive inheritance of von Willebrand disease with abnormal binding of von Willebrand factor to factor VIII. López-Fernández MF; Blanco-López MJ; Castiñeira MP; Batlle J Am J Hematol; 1992 May; 40(1):20-7. PubMed ID: 1566742 [TBL] [Abstract][Full Text] [Related]
29. Genetic defects and clinical characteristics of patients with a form of oculocutaneous albinism (Hermansky-Pudlak syndrome). Gahl WA; Brantly M; Kaiser-Kupfer MI; Iwata F; Hazelwood S; Shotelersuk V; Duffy LF; Kuehl EM; Troendle J; Bernardini I N Engl J Med; 1998 Apr; 338(18):1258-64. PubMed ID: 9562579 [TBL] [Abstract][Full Text] [Related]
30. Acquired Von Willebrand syndrome in patients on long-term support with HeartMate II. Heilmann C; Trummer G; Beyersdorf F; Brehm K; Berchtold-Herz M; Schelling J; Geisen U; Zieger B Eur J Cardiothorac Surg; 2017 Mar; 51(3):587-590. PubMed ID: 28082469 [TBL] [Abstract][Full Text] [Related]
31. Outgrowing the laboratory diagnosis of type 1 von Willebrand disease: A two decade study. Abou-Ismail MY; Ogunbayo GO; Secic M; Kouides PA Am J Hematol; 2018 Feb; 93(2):232-237. PubMed ID: 29098718 [TBL] [Abstract][Full Text] [Related]
32. Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals. Schleef M; Strobel E; Dick A; Frank J; Schramm W; Spannagl M Br J Haematol; 2005 Jan; 128(1):100-7. PubMed ID: 15606555 [TBL] [Abstract][Full Text] [Related]
33. Von Willebrand factor antigen for detection of hepatopulmonary syndrome in patients with cirrhosis. Horvatits T; Drolz A; Roedl K; Herkner H; Ferlitsch A; Perkmann T; Müller C; Trauner M; Schenk P; Fuhrmann V J Hepatol; 2014 Sep; 61(3):544-9. PubMed ID: 24798623 [TBL] [Abstract][Full Text] [Related]
34. Intraplatelet von Willebrand factor and ABO blood group. Sweeney JD; Hoernig LA Thromb Res; 1992 Dec; 68(4-5):393-8. PubMed ID: 1290167 [TBL] [Abstract][Full Text] [Related]
35. Hermansky-Pudlak syndrome: health care throughout life. Seward SL; Gahl WA Pediatrics; 2013 Jul; 132(1):153-60. PubMed ID: 23753089 [TBL] [Abstract][Full Text] [Related]
36. Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management. Michiels JJ; van Vliet HH Acta Haematol; 2009; 121(2-3):154-66. PubMed ID: 19506362 [TBL] [Abstract][Full Text] [Related]
37. Low von Willebrand factor: sometimes a risk factor and sometimes a disease. Sadler JE Hematology Am Soc Hematol Educ Program; 2009; ():106-12. PubMed ID: 20008188 [TBL] [Abstract][Full Text] [Related]
38. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease. Shihong I; Morris D; Konkle BA Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254 [TBL] [Abstract][Full Text] [Related]
39. The significance of evaluating conventional inflammatory markers in Von Willebrand factor measurement. Lippi G; Franchini M; Targher G; Poli G; Guidi GC Clin Chim Acta; 2007 Jun; 381(2):167-70. PubMed ID: 17433810 [TBL] [Abstract][Full Text] [Related]
40. Platelet function and ABO blood group. Sweeney JD; Labuzetta JW; Hoernig LA; Fitzpatrick JE Am J Clin Pathol; 1989 Jan; 91(1):79-81. PubMed ID: 2491926 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]